Experienced in Genital Herpes

Dr. Onyema E. Ogbuagu

Infectious Disease
Yale University
800 Howard Ave, 
New Haven, CT 
Experienced in Genital Herpes
Yale University
800 Howard Ave, 
New Haven, CT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Onyema Ogbuagu is an Infectious Disease provider in New Haven, Connecticut. Dr. Ogbuagu is rated as an Experienced provider by MediFind in the treatment of Genital Herpes. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, AIDS Dysmorphic Syndrome, and Endoscopy.

His clinical research consists of co-authoring 77 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Genital Herpes.

Specialties
Infectious Disease
Licenses
Internal Medicine in CT
Hospital Affiliations
Yale-New Haven Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

YALE UNIVERSITY
800 Howard Ave, New Haven, CT 06519
Other Locations
YALE UNIVERSITY
20 York St, New Haven, CT 06510

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)
A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Drug
Study Drug: Leronlimab
Study Phase: Phase 2
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Study Drugs: Cabotegravir, Rilpivirine, BIKTARVY
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Open-label, Non-inferiority Study Evaluating the Efficacy, Safety and Tolerability of Switching to Dolutegravir/Lamivudine Fixed Dose Combination in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Open-label, Non-inferiority Study Evaluating the Efficacy, Safety and Tolerability of Switching to Dolutegravir/Lamivudine Fixed Dose Combination in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: October 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Current antiretroviral regimen
Study Phase: Phase 3
A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate Coronavirus Disease 2019 (COVID-19)
A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate Coronavirus Disease 2019 (COVID-19)
Enrollment Status: Completed
Publish Date: January 04, 2023
Intervention Type: Drug
Study Drug: Leronlimab
Study Phase: Phase 2
A Study of the Pharmacokinetic and Pharmacodynamic Interactions Between Bictegravir, Tenofovir Alafenamide and Rifapentine in Healthy Adult Subjects
A Study of the Pharmacokinetic and Pharmacodynamic Interactions Between Bictegravir, Tenofovir Alafenamide and Rifapentine in Healthy Adult Subjects
Enrollment Status: Withdrawn
Publish Date: September 20, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 4 Less Clinical Trials

77 Total Publications

New strategies for a vexing problem: injectables to the rescue for people with Multidrug-Resistant HIV.
New strategies for a vexing problem: injectables to the rescue for people with Multidrug-Resistant HIV.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 12, 2025
Similar Doctors
Marla J. Keller
Advanced in Genital Herpes
Dr. Marla J. Keller
Infectious Disease
Advanced in Genital Herpes
Dr. Marla J. Keller
Infectious Disease

Montefiore Medical Center

111 East 210th Street, 
Bronx, NY 
 (56.6 miles away)
718-430-3240
Languages Spoken:
English
See accepted insurances

Marla Keller, MD is a tenured Professor of Medicine, Obstetrics & Gynecology and Women’s Health, named holder of the Jacob and Jeanne Barkey Chair in Medicine, and Executive Dean. She previously served as Interim Senior Associate Dean for Clinical and Translational Research, Director of the Harold and Muriel Block Institute for Clinical and Translational Research, and Vice Chair of Research for the Department of Medicine. Her clinical focus centers on treating HIV and COVID-19 and offering in-patient infectious disease consultation. Dr. Keller is rated as an Advanced provider by MediFind in the treatment of Genital Herpes. Her top areas of expertise are Genital Herpes, HIV/AIDS, Human Papillomavirus Infection, and Hepatitis C.

Experienced in Genital Herpes
Dr. Paul F. Nee
Infectious Disease
Experienced in Genital Herpes
Dr. Paul F. Nee
Infectious Disease

Nuvance Health Medical Practice Ct Inc

24 Hospital Ave, 
Danbury, CT 
 (27.4 miles away)
203-739-7118
Languages Spoken:
English
See accepted insurances

Paul Nee is an Infectious Disease provider in Danbury, Connecticut. Dr. Nee is rated as an Advanced provider by MediFind in the treatment of Genital Herpes. His top areas of expertise are Cellulitis, Pseudomonas Stutzeri Infections, Endocarditis, and Osteomyelitis.

Experienced in Genital Herpes
Dr. Sarah A. Humphreys
Infectious Disease
Experienced in Genital Herpes
Dr. Sarah A. Humphreys
Infectious Disease

Community Health And Wellness Center Of Greater Torrington Inc

469 Migeon Ave, 
Torrington, CT 
 (36.7 miles away)
860-489-0931
Experience:
10+ years
Languages Spoken:
English
See accepted insurances

Sarah Humphreys is an Infectious Disease provider in Torrington, Connecticut. Dr. Humphreys has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Genital Herpes. Her top areas of expertise are Listeriosis, Syphilis, Gonorrhea, and Myelitis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ogbuagu's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile